NLRP3 and mTOR Reciprocally Regulate Macrophage Phagolysosome Formation and Acidification AgainstVibrio vulnificusInfection
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Authors: Huang, Xian-Hui; Ma, Yao; Zheng, Meng-Meng; Chen, Na; Hu, Mei-Na; Wu, Liu-Ying; Zheng, Yi; Lou, Yong-Liang; Xie, Dan-Li
Abstract
The marine bacteriumVibrio vulnificuscauses potentially fatal bloodstream infections, typically in patients with chronic liver diseases. The inflammatory response and anti-bacterial function of phagocytes are crucial for limiting bacterial infection in the human hosts. HowV. vulnificusaffects macrophages after phagocytosis is unclear. In this report, we found that the bactericidal activity of macrophages to internalizeV. vulnificuswas dependent on mammalian target of rapamycin (mTOR) and NOD-like receptor (NLR) family pyrin domain containing 3 (NLRP3) interaction. Additionally, the NLRP3 expression was dependent on mTORC1 activation. Inhibited mTORC1 or absence of NLRP3 in macrophages impairedV. vulnificus-induced phagosome acidification and phagolysosome formation, leading to a reduction of intracellular bacterial clearance. mTORC1 signaling overactivation could increase NLRP3 expression and restore insufficient phagosome acidification. Together, these findings indicate that the intracellular bactericidal activity of macrophages responding toV. vulnificusinfection is tightly controlled by the crosstalk of NLRP3 and mTOR and provide critical insight into the host bactericidal activity basis of clearance ofV. vulnificusthrough lyso/phagosome.
Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling
CANCER MEDICINE
Authors: Xie, Gangyin; Sun, Linxiao; Li, Yonglin; Chen, Bicheng; Wang, Cheng
Abstract
Background Periplocin is a monomeric compound that exhibits anti-tumor activities. It is extracted from Cortex Periplocae. Objective This study aimed at determining the effect of periplocin treatment on the apoptosis and proliferation of human pancreatic cancer cells, and to elucidate on its mechanisms of action. Methods PANC1 and cfpac1 cells were treated with periplocin. Cell proliferation was detected by RTCA, Ki67 immunofluorescence, and a clonogenic assay. The transwell assay was used to examine cell migration and invasion functions. The expression of apoptosis-associated proteins was detected by flow cytometry and western blotting. Total RNA was extracted from the treated and untreated group of PANC1 cells for RNA-seq detection and analysis. Differentially expressed genes were screened for GO biological process and KEGG pathway analysis. Finally, CFPAC1 cells were subcutaneously inoculated into BALB / c nude mice to assess tumor growth. Results Periplocin inhibited the proliferation of PANC1 and CFPAC1 cells and induced their apoptosis by activating the AMPK/mTOR pathway and inhibiting p70 S6K. It also attenuated the cell migration, invasion, and inhibited the growth of cfpac1 xenografts in nude mice. Conclusions Periplocin inhibits human pancreatic cancer cell proliferation and induces their apoptosis by activating the AMPK / mTOR pathway.